{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:05:53Z","timestamp":1791839153204,"version":"4.3.4"},"reference-count":156,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.clindermatol.2023.12.004","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T16:38:28Z","timestamp":1703263108000},"page":"169-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["HIV: Inflammatory dermatoses"],"prefix":"10.1016","volume":"42","author":[{"given":"Robert","family":"Bobotsis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakira","family":"Brathwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panteha","family":"Eshtiaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Rodriguez-Bolanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Doiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2023.12.004_bib0001","doi-asserted-by":"crossref","first-page":"980","DOI":"10.12688\/f1000research.16182.1","article-title":"What's new in HIV dermatology?","volume":"8","author":"Coates","year":"2019","journal-title":"F1000 Faculty Rev"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.sder.2011.04.004","article-title":"Approach to pruritus in the adult HIV-positive patient","volume":"30","author":"Serling","year":"2011","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0003","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2009.03.047","article-title":"Psoriasis in patients with HIV infection: from the Medical Board of the National Psoriasis Foundation","volume":"62","author":"Menon","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/OARRR.S87312","article-title":"Rheumatoid arthritis in patients with HIV: management challenges","volume":"8","author":"Carroll","year":"2016","journal-title":"Open Access Rheumatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0005","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jdcr.2020.09.023","article-title":"Dupilumab in HIV-positive patients: a case series report of 4 patients","volume":"6","author":"Alawadhi","year":"2020","journal-title":"JAAD Case Reports"},{"issue":"8","key":"10.1016\/j.clindermatol.2023.12.004_bib0006","doi-asserted-by":"crossref","DOI":"10.5070\/D327854709","article-title":"Dupilumab in HIV-positive patients with atopic dermatitis: a long-term follow-up patient and a literature review","volume":"27","author":"Avallone","year":"2021","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0007","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/bjd.18222","article-title":"Use of dupilumab in patients who are HIV-positive: report of four cases","volume":"181","author":"Mollanazar","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0008","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4049\/jimmunol.164.2.589","article-title":"HIV-1 gp120 induces IL-4 and IL-13 release from human Fc\u03b5RI + cells through interaction with the V H 3 region of IgE","volume":"164","author":"Patella","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0009","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11262-005-2503-5","article-title":"The molecular mechanism of human resistance to HIV-1 infection in persistently infected individuals: a review, hypothesis and implications","volume":"31","author":"Becker","year":"2005","journal-title":"Virus Genes"},{"issue":"9038","key":"10.1016\/j.clindermatol.2023.12.004_bib156","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(95)12269-2","article-title":"Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya","volume":"348","author":"Fowke","year":"1996","journal-title":"The Lancet"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/DER.0000000000000845","article-title":"Systemic therapy for atopic dermatitis in older adults and adults with comorbidities: a scoping review and International Eczema Council survey","volume":"33","author":"Drucker","year":"2022","journal-title":"Dermatitis"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0011","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-110-11-937","article-title":"Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS)","volume":"10","author":"Gill","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0012","doi-asserted-by":"crossref","first-page":"e12806","DOI":"10.1111\/dth.12806","article-title":"HIV-associated psoriasis: epidemiology, pathogenesis, and management","volume":"32","author":"Ceccarelli","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0013","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/0956462419827673","article-title":"Psoriasis in HIV infection: an update","volume":"30","author":"Alpalh\u00e3o","year":"2019","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0014","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QAI.0000000000001431","article-title":"HIV infection increases the risk of incident psoriasis: a nationwide population-based cohort study in Taiwan","volume":"75","author":"Yen","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0015","doi-asserted-by":"crossref","first-page":"e52845","DOI":"10.1371\/journal.pone.0052845","article-title":"Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV Indicator Diseases across Europe Study)","volume":"8","author":"Sullivan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220108","article-title":"Improving the evidence for indicator condition guided HIV testing in Europe: results from the HIDES II study \u20132012-2015","volume":"14","author":"Raben","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0017","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1473-3099(10)70101-8","article-title":"HIV-associated psoriasis: pathogenesis, clinical features, and management","volume":"10","author":"Morar","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0018","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0190-9622(94)70175-X","article-title":"The use of methotrexate for treatment of psoriasis in patients with HIV infection","volume":"31","author":"Maurer","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0019","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0190-9622(97)70160-9","article-title":"Alleviation of HIV-associated psoriasis and psoriatic arthritis with cyclosporine","volume":"37","author":"Tourne","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0020","first-page":"297","article-title":"Use of cyclosporin for psoriasis in HIV-positive patient","volume":"88","author":"Allen","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0021","article-title":"Treatment of moderate to severe psoriasis with apremilast over 2 years in the context of long-term treated HIV infection: a case report","volume":"7","author":"Zarbafian","year":"2019","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0022","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/ijd.IJD_633_18","article-title":"Apremilast in people living with HIV with psoriasis vulgaris: a case report","volume":"64","author":"Shah","year":"2019","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0023","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4065\/75.10.1093","article-title":"Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis","volume":"75","author":"Aboulafia","year":"2000","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0024","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2340\/00015555-2698","article-title":"Biologic therapies in HIV-infected patients with psoriasis: an Italian experience","volume":"97","author":"Bardazzi","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0025","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2007.081513","article-title":"The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease","volume":"67","author":"Cepeda","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"1 suppl","key":"10.1016\/j.clindermatol.2023.12.004_bib0026","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0300060515593250","article-title":"Treatment of psoriasis with etanercept in immunocompromised patients: two case reports","volume":"44","author":"de Simone","year":"2016","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0027","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4103\/0378-6323.110807","article-title":"Long-term management of HIV\/hepatitis C virus associated psoriasis with etanercept","volume":"79","author":"Di Lernia","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0028","first-page":"413","article-title":"Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study","volume":"11","author":"Lee","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0029","first-page":"1353","article-title":"Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection","volume":"34","author":"Linardaki","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archderm.144.4.453","article-title":"Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus","volume":"144","author":"Mikhail","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0031","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3109\/09546634.2011.579085","article-title":"Ustekinumab for the treatment of HIV psoriasis","volume":"23","author":"Paparizos","year":"2012","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0032","first-page":"869","article-title":"Treatment of severe psoriasis and psoriatic arthritis with adalimumab in an HIV-positive patient","volume":"13","author":"Lindsey","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0033","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/jdv.12531","article-title":"Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection","volume":"29","author":"Saeki","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0034","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.0007-0963.2004.05885.x","article-title":"Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab","volume":"150","author":"Bartke","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jbspin.2006.05.012","article-title":"Use of infliximab to treat psoriatic arthritis in HIV-positive patients","volume":"74","author":"Sellam","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0036","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.22955","article-title":"Rates of serious infections in HIV-infected patients receiving tumor necrosis factor inhibitor therapy for concomitant autoimmune diseases","volume":"69","author":"Wangsiricharoen","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0037","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/ced.13630","article-title":"Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma","volume":"44","author":"Wang","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0038","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/247553031420a00304","article-title":"Treatment of refractory psoriasis with ustekinumab in an HIV-positive patient: a case presentation and review of the biologic literature","volume":"20","author":"Wieder","year":"2014","journal-title":"Psoriasis Forum"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0039","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000508781","article-title":"Use of anti-IL-17 monoclonal antibodies in HIV patients with erythrodermic psoriasis","volume":"12","author":"Pangilinan","year":"2020","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0040","first-page":"646","article-title":"Secukinumab in an HIV-positive patient with psoriasis","volume":"17","author":"Di Lernia","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0041","doi-asserted-by":"crossref","first-page":"e13895","DOI":"10.1111\/dth.13895","article-title":"Brodalumab: another helpful option for HIV-positive psoriatic patients?","volume":"33","author":"Di Lernia","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0042","doi-asserted-by":"crossref","DOI":"10.5070\/D32411041999","article-title":"Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review","volume":"24","author":"Bartos","year":"2018","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0043","doi-asserted-by":"crossref","first-page":"e15277","DOI":"10.1111\/dth.15277","article-title":"Successful treatment of psoriasis with risankizumab in an HIV positive patient with sexually transmitted infection comorbidities","volume":"35","author":"Rob","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0044","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: Which therapy for which patient: focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0045","first-page":"38","article-title":"Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies","volume":"101","author":"Nakamura","year":"2018","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0046","first-page":"158","article-title":"Observation CXVIII","volume":"2","author":"Tarral","year":"1835"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0047","first-page":"197","article-title":"Pityriasis pilaris, maladie de peau non d\u00e9crite par les dermatologistes [Pityriasis pilaris, skin disease not described by dermatologists]","volume":"3","author":"Devergie","year":"1856","journal-title":"Gazette Hebdomadaire Med Chir"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0048","first-page":"398","article-title":"Observations pour servir a l\u2019histoire clinique du pityriasis rubra pilaire [Observations to be used in the clinical history of pityriasis rubra pilaris]","volume":"11","author":"Besnier","year":"1869","journal-title":"Ann Dermatol Syphiligr (Paris)"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0049","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2230.1980.tb01676.x","article-title":"Pityriasis rubra pilaris","volume":"5","author":"Griffiths","year":"1980","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0050","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/0190-9622(90)70173-F","article-title":"Papulosquamous dermatoses of AIDS","volume":"22","author":"Sadick","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0051","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.1995.tb06939.x","article-title":"Pityriasis rubra pilaris and human immunodeficiency virus infection","volume":"133","author":"Miralles","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0052","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajhg.2012.05.010","article-title":"Familial pityriasis rubra pilaris is caused by mutations in CARD14","volume":"91","author":"Fuchs-Telem","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0053","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2133.1981.tb00946.x","article-title":"Pityriasis rubra pilaris and retinol-binding protein","volume":"104","author":"Finzi","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0054","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/000155599750010517","article-title":"Pityriasis rubra pilaris: a retrospective analysis of 43 patients","volume":"79","author":"S\u00f8rensen","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0055","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1525-1470.2002.00236_5.x","article-title":"Further clinical evidence for involvement of bacterial superantigens in juvenile pityriasis rubra pilaris (PRP): report of two cases","volume":"19","author":"M\u00f6hrenschlager","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0056","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40257-017-0338-1","article-title":"A review on pityriasis rubra pilaris","volume":"19","author":"Wang","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0057","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/jdv.14761","article-title":"Pityriasis rubra pilaris: algorithms for diagnosis and treatment","volume":"32","author":"Roenneberg","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0058","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2230.2004.01571.x","article-title":"Spontaneous clinical improvement in HIV-associated follicular syndrome","volume":"29","author":"Blasdale","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0059","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2016.0091","article-title":"Epidemiologic, clinicopathologic, diagnostic, and management challenges of pityriasis rubra pilaris: a case series of 100 patients","volume":"152","author":"Ross","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0060","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.1999.02829.x","article-title":"HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy","volume":"140","author":"Gonzalez-Lopez","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0061","first-page":"522","article-title":"Atypical adult-onset pityriasis rubra pilaris in an HIV-positive adult male","volume":"63","author":"Nair","year":"2018","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0062","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/742826","article-title":"Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis","volume":"2014","author":"Gorouhi","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0063","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1600-0714.2008.00662.x","article-title":"The reported prevalence of oral lichen planus: a review and critique","volume":"37","author":"McCartan","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0064","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/archderm.142.7.954","article-title":"A novel visual clue for the diagnosis of hypertrophic lichen planus","volume":"142","author":"Welsh","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0065","first-page":"143","article-title":"Lichen planus in tropical Africa","volume":"33","author":"Alabi","year":"1981","journal-title":"Trop Geogr Med"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0066","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1600-0781.2010.00548.x","article-title":"Actinic lichen planus in a Japanese man: first case in the East Asian population","volume":"26","author":"Dekio","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0067","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2003.08.011","article-title":"Annular lichen planus: a case series of 20 patients","volume":"50","author":"Reich","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0068","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijwd.2015.04.001","article-title":"Update on lichen planus and its clinical variants","volume":"1","author":"Weston","year":"2015","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0069","first-page":"225","article-title":"Unilateral multiple linear lichen planus along the lines of Blaschko: a report of two cases","volume":"65","author":"Sharma","year":"1999","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/idoj.IDOJ_254_20","article-title":"Unilateral linear lichen planus hypertrophicus along Blaschko's lines","volume":"12","author":"Kapoor","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0071","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2230.2003.01367.x","article-title":"A study of 124 Indian patients with lichen planus pigmentosus","volume":"28","author":"Kanwar","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0072","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1346-8138.2011.01283.x","article-title":"Lichen planus pigmentosus-inversus occurring extensively in multiple intertriginous areas","volume":"39","author":"Ohshima","year":"2012","journal-title":"J Dermatol"},{"issue":"6 suppl 1","key":"10.1016\/j.clindermatol.2023.12.004_bib0073","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1590\/abd1806-4841.20132599","article-title":"Lichen planus pigmentosus inversus","volume":"88","author":"Barros","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0074","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2133.1961.tb14448.x","article-title":"The nails in lichen planus","volume":"73","author":"Samman","year":"1961","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0560.1994.tb00691.x","article-title":"Hypertrophic lichen planus in three HIV-positive patients: a histologic and immunological study","volume":"21","author":"Rippis","year":"1994","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0076","first-page":"109","article-title":"Photodistributed hypertrophic lichen planus in association with acquired immunodeficiency syndrome: a distinct entity","volume":"55","author":"Fitzgerald","year":"1995","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0077","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5070\/D34HJ0G8H3","article-title":"Extensive hypertrophic lichen planus in an HIV positive patient","volume":"16","author":"Emadi","year":"2010","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0078","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-4362.1988.tb02423.x","article-title":"Hypertrophic lichen planus and light sensitivity in an HIV-positive patient","volume":"27","author":"Pardo","year":"1988","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0079","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/ijstd.IJSTD_130_15","article-title":"Correlating CD4 count with mucocutaneous manifestations in HIV-positive patients: a prospective study","volume":"38","author":"Chandrakala","year":"2017","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0377-1237(04)80054-6","article-title":"Orocutaneous manifestations as markers of disease progression in HIV infection in Indian setting","volume":"60","author":"Sharma","year":"2004","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0081","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jdcr.2015.04.008","article-title":"Generalized annular lichen planus with a unique morphology in a patient seropositive for HIV","volume":"1","author":"Chakraborty","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0082","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0019-5154.45431","article-title":"Hypertrophic lichen planus as a presenting feature of human immunodeficiency virus infection","volume":"54","author":"Kumari","year":"2009","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0083","first-page":"75","article-title":"Scalp involvement by Sarcoptes scabiei var hominis resembling seborrhoeic dermatitis in two immunocompromised patients with systemic lupus erythematosus","volume":"126","author":"Birry","year":"2013","journal-title":"N Z Med J"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0084","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM198601303140511","article-title":"Tinea faciale mimicking seborrheic dermatitis in a patient with AIDS","volume":"314","author":"Perniciaro","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0536.2006.00839.x","article-title":"Contact allergy to propylene glycol and dodecyl gallate mimicking seborrheic dermatitis","volume":"55","author":"Kuznetsov","year":"2006","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0086","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/bjd.17826","article-title":"Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population-based study in 161 269 employees","volume":"181","author":"Zander","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0087","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0190-9622(85)70243-5","article-title":"Seborrheic dermatitis in patients with acquired immunodeficiency syndrome","volume":"13","author":"Mathes","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0088","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0956462414543121","article-title":"Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count","volume":"26","author":"Fernandes","year":"2015","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0089","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1258\/ijsa.2009.009092","article-title":"Mucocutaneous manifestations in 150 HIV-infected Indian patients and their relationship with CD4 lymphocyte counts","volume":"20","author":"Sud","year":"2009","journal-title":"Int J STD AIDS"},{"issue":"suppl 2","key":"10.1016\/j.clindermatol.2023.12.004_bib0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-4632.2007.03349.x","article-title":"Correlation of mucocutaneous manifestations of HIV\/AIDS infection with CD4 counts and disease progression","volume":"46","author":"Nnoruka","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0091","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1177\/0956462416641816","article-title":"Diffuse HIV-associated seborrheic dermatitis: a case series","volume":"27","author":"Forrestel","year":"2016","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0092","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.01.001","article-title":"Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies","volume":"31","author":"Dessinioti","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0093","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1439-0507.2009.01814.x","article-title":"Minireview: Malassezia infections in immunocompromised patients","volume":"53","author":"Tragiannidis","year":"2010","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0094","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.jid.5701017","article-title":"Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects","volume":"128","author":"Tajima","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0190-9622(90)70191-J","article-title":"Correlation of Pityosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique","volume":"23","author":"Heng","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0096","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0190-9622(92)70153-7","article-title":"Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis","volume":"27","author":"Wikler","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib155","first-page":"344","article-title":"Distribution of Malassezia species in seborrhoeic dermatitis: correlation with patients\u2019 cellular immune status","volume":"53","author":"Prohic","year":"2010","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0097","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1087-0024.2005.10119.x","article-title":"Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity","volume":"10","author":"DeAngelis","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0098","doi-asserted-by":"crossref","first-page":"523","DOI":"10.5021\/ad.2015.27.5.523","article-title":"Maintenance therapy of facial seborrheic dermatitis with 0.1% tacrolimus ointment","volume":"27","author":"Kim","year":"2015","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0099","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/11311160-000000000-00000","article-title":"Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study","volume":"11","author":"Ozden","year":"2010","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-3083.2006.01923.x","article-title":"An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV","volume":"21","author":"de Moraes","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0101","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009446.pub2","article-title":"Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp","author":"Kastarinen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0102","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/CCID.S344807","article-title":"Facial seborrheic dermatitis in HIV-seropositive patients: evaluation of the efficacy and safety of a non-steroidal cream containing piroctone olamine, biosaccharide gum-2 and stearyl glycyrrhetinate\u2014a case series","volume":"15","author":"Cortes-Correa","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0103","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09546634.2018.1473554","article-title":"Treatment of seborrheic dermatitis: a comprehensive review","volume":"30","author":"Borda","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0104","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/17425255.2014.883379","article-title":"Clinically relevant drug-drug interactions between antiretrovirals and antifungals","volume":"10","author":"Vadlapatla","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jaad.2006.02.034","article-title":"Eosinophilic pustular folliculitis: a 40 year retrospect","volume":"55","author":"Nervi","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0106","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archderm.1991.01680020074008","article-title":"Human immunodeficiency virus-associated eosinophilic folliculitis: a unique dermatosis associated with advanced human immunodeficiency virus infection","volume":"127","author":"Rosenthal","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0107","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1085-5629(97)80045-4","article-title":"HIV-related eosinophilic folliculitis: a panel discussion","volume":"16","author":"Majors","year":"1997","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0108","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.1999.02914.x","article-title":"Itchy folliculitis and human immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment","volume":"141","author":"Fearfield","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0109","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/00128071-200607030-00006","article-title":"Eosinophilic folliculitis in HIV-infected women: case series and review","volume":"7","author":"Parker","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0110","first-page":"195","article-title":"Eosinophilic pustular folliculitis","volume":"50","author":"Ofuji","year":"1970","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0111","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1365-4362.2000.00973.x","article-title":"Necrotizing eosinophilic folliculitis as a manifestation of the atopic diathesis","volume":"39","author":"Magro","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0112","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/archderm.141.10.1227","article-title":"Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy","volume":"141","author":"Rajendran","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0113","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00128071-200405030-00007","article-title":"Eosinophilic pustular folliculitis: a comprehensive review of treatment options","volume":"5","author":"Ellis","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0114","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/sti.75.5.291","article-title":"HIV associated eosinophilic folliculitis: differential diagnosis and management","volume":"75","author":"Simpson-Dent","year":"1999","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s15010-020-01543-z","article-title":"Eosinophilic pustular folliculitis (EPF) in a patient with HIV infection","volume":"49","author":"Kanaki","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0116","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/1346-8138.13287","article-title":"Eosinophilic pustular folliculitis: a published work-based comprehensive analysis of therapeutic responsiveness","volume":"43","author":"Nomura","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2340\/00015555-0578","article-title":"Therapeutic effectiveness of various treatments for eosinophilic pustular folliculitis","volume":"89","author":"Fukamachi","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0118","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archderm.141.10.1203","article-title":"Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infection","volume":"141","author":"Toutous-Trellu","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0119","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archderm.1995.01690210121026","article-title":"Metronidazole for eosinophilic pustular folliculitis in human immunodeficiency virus type 1-positive patients","volume":"131","author":"Smith","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archderm.1995.01690150124031","article-title":"Itraconazole therapy for human immunodeficiency virus-associated eosinophilic folliculitis","volume":"131","author":"Berger","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0121","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archderm.1995.01690210077012","article-title":"Isotretinoin treatment of human immunodeficiency virus-associated eosinophilic folliculitis: results of an open, pilot trial","volume":"131","author":"Otley","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0122","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0190-9622(86)70126-6","article-title":"Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome: report of three cases","volume":"14","author":"Soeprono","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0123","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-4362.1993.tb02762.x","article-title":"Pruritic papular eruption of HIV-disease","volume":"32","author":"Bason","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0124","first-page":"117","article-title":"Generalized papular pruritic eruption in African patients with human immunodeficiency virus infection","volume":"1","author":"Colebunders","year":"1987","journal-title":"AIDS"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0125","first-page":"501","article-title":"Pruritic papular eruptions of HIV: a clinicopathologic and therapeutic study","volume":"4","author":"Lakshmi","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0190-9622(91)70033-X","article-title":"Pruritic papular eruption of the acquired immunodeficiency syndrome: a clinicopathologic study","volume":"24","author":"Hevia","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0127","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1001\/jama.292.21.2614","article-title":"Etiology of pruritic papular eruption with HIV infection in Uganda","volume":"292","author":"Resneck","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0190-9622(89)80051-9","article-title":"Chronic pruritic eruption in patients with acquired immunodeficiency syndrome associated with increased antibody titers to mosquito salivary gland antigens","volume":"21","author":"Penneys","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0129","series-title":"The Use of Antiretroviral Drugs for Treating and Preventing HIV Infection","year":"2016"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/QAD.0b013e3282f313a9","article-title":"Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?","volume":"22","author":"Castelnuovo","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/ijstd.IJSTD_22_17","article-title":"Inflammatory dermatoses in human immunodeficiency virus","volume":"38","author":"Garg","year":"2017","journal-title":"Indian J Sexually Transmitted Dis"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0132","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1473-3099(05)70327-3","article-title":"A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries","volume":"6","author":"Colebunders","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0133","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ijd.14725","article-title":"Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV\/AIDS patients in Yunnan, China","volume":"59","author":"Li","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0134","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-4362.1999.00694.x","article-title":"Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression","volume":"38","author":"Boonchai","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0253-7184.112865","article-title":"Pattern of mucocutaneous manifestations in human immunodeficiency virus-positive patients in North India","volume":"34","author":"Kore","year":"2013","journal-title":"Indian J Sex Transm Dis"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0136","series-title":"Hospital-Based Dermatopathology","first-page":"823","article-title":"Human immunodeficiency virus (HIV)-associated dermatoses and malignancy","author":"Grayson","year":"2020"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0137","unstructured":"Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults. In: WHO Guidelines Approved by the Guidelines Review Committee. Geneva, Switzerland: World Health Organization; 2014."},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0138","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0190-9622(92)70067-P","article-title":"UVB phototherapy of the pruritic papular eruption of the acquired immunodeficiency syndrome","volume":"26","author":"Pardo","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"6 Pt 1","key":"10.1016\/j.clindermatol.2023.12.004_bib0139","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0190-9622(98)70159-8","article-title":"Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons","volume":"38","author":"Berman","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0140","doi-asserted-by":"crossref","first-page":"A109","DOI":"10.1016\/j.jdcr.2015.02.007","article-title":"Thalidomide-a novel therapeutic approach for pruritic papular eruption of HIV","volume":"1","author":"Wernham","year":"2015","journal-title":"JAAD Case Reports"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0141","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-4632.2009.04279.x","article-title":"Antihistamines are superior to topical steroids in managing human immunodeficiency virus (HIV)-associated papular pruritic eruption","volume":"49","author":"Navarini","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0142","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/ijstd.IJSTD_69_18","article-title":"Prevalence of pruritic papular eruption among HIV patients: a cross-sectional study","volume":"40","author":"Mohammed","year":"2019","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0143","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2340\/00015555-0305","article-title":"Clinical classification of itch: a position paper of the international forum for the study of itch","volume":"87","author":"St\u00e4nder","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0144","first-page":"161","article-title":"Chronic pruritus","volume":"147","author":"Yosipovitch","year":"2012","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0145","doi-asserted-by":"crossref","first-page":"12365","DOI":"10.3390\/ijms222212365","article-title":"Connections between immune-derived mediators and sensory nerves for itch sensation","volume":"22","author":"Toyama","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0146","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jpainsymman.2018.01.014","article-title":"Prevalence and characteristics of pruritus and association with quality of life in people living with HIV: a cross-sectional study","volume":"55","author":"Xu","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0147","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archderm.1989.01670170043005","article-title":"Pruritic skin lesions a common initial presentation of acquired immunodeficiency syndrome from the Haitian Study Group on Kaposi's sarcoma and opportunistic infection, Port-au-Prince","volume":"125","author":"Liautaud","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0148","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jaad.2013.12.015","article-title":"Chronic pruritus in HIV-positive patients in the southeastern United States: its prevalence and effect on quality of life","volume":"70","author":"Kaushik","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0149","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1258\/ijsa.2009.009189","article-title":"Pruritus in HIV-infected patients in the era of combination antiretroviral therapy: a study of its prevalence and causes","volume":"23","author":"Blanes","year":"2012","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00128071-200304030-00004","article-title":"HIV-associated pruritus etiology and management","volume":"4","author":"Singh","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0151","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1034\/j.1398-9995.1999.00885.x","article-title":"Intractable pruritus in HIV infection: immunologic characterization","volume":"54","author":"Milazzo Piconi","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0152","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0738-081X(99)00143-1","article-title":"Pruritus and cutaneous inflammatory conditions in HIV disease","volume":"18","author":"Rodwell","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0153","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/infdis\/174.3.615","article-title":"Eosinophilia in patients infected with human immunodeficiency virus","volume":"174","author":"Cohen","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clindermatol.2023.12.004_bib0154","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2005.12.030","article-title":"Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience","volume":"54","author":"Zancanaro","year":"2006","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23002560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23002560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T18:49:35Z","timestamp":1730918975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X23002560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":156,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0738081X23002560"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.12.004","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV: Inflammatory dermatoses","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}